Preoperative Warfarin Treatment and Outcome of Coronary Artery Bypass Graft Surgery Fausto Biancari, MD, PhD, Mikko Myllylä, BM, Samuli Lepojärvi, MD,

Preoperative Warfarin Treatment and Outcome of Coronary Artery Bypass Graft Surgery
Fausto Biancari, MD, PhD, Mikko Myllylä, BM, Samuli Lepojärvi, MD, Kari Kuttila, MD, PhD, Pekka Porela, MD, PhD, Timo Laitio, MD, PhD, Antti Ylitalo, MD, PhD, Vesa Jokinen, MD, PhD, Antti Luokkala, MD, K.E. Juhani Airaksinen, MD, PhD The Annals of Thoracic Surgery Volume 89, Issue 4, Pages (April 2010) DOI: /j.athoracsur Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Postoperative complications and the use of blood products in the warfarin and control groups after elective (A) and urgent or emergent operations (B). Severe complications were defined as death, stroke, resternotomy, or stay in intensive care unit of at least 5 days. (FFP = fresh-frozen plasma; RBC = red blood cell; restern = resternotomoy.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Preoperative Warfarin Treatment and Outcome of Coronary Artery Bypass Graft Surgery Fausto Biancari, MD, PhD, Mikko Myllylä, BM, Samuli Lepojärvi, MD,

Samankaltaiset esitykset

Esitys aiheesta: "Preoperative Warfarin Treatment and Outcome of Coronary Artery Bypass Graft Surgery Fausto Biancari, MD, PhD, Mikko Myllylä, BM, Samuli Lepojärvi, MD,"— Esityksen transkriptio:

Samankaltaiset esitykset

Projektista

Palaute

Kirjaudu sisään

Kirjaudu sisään sosiaaliverkostojen kautta:

Preoperative Warfarin Treatment and Outcome of Coronary Artery Bypass Graft Surgery Fausto Biancari, MD, PhD, Mikko Myllylä, BM, Samuli Lepojärvi, MD,

Samankaltaiset esitykset

Esitys aiheesta: "Preoperative Warfarin Treatment and Outcome of Coronary Artery Bypass Graft Surgery Fausto Biancari, MD, PhD, Mikko Myllylä, BM, Samuli Lepojärvi, MD,"— Esityksen transkriptio:

Samankaltaiset esitykset

Projektista

Palaute